Cutia Therapeutics (SEHK: 2487)
Health Care · Biotechnology · CN
HK$0.86
+0.58% today · -89.6% 1Y
Cutia Therapeutics (SEHK: 2487) operates in the Biotechnology industry within the Health Care sector. The company is valued at $40.89M and employs 268 people.
Over the last twelve months the share price has lost 89.6%, trading between 0.60 and 8.87.
Tweenvest scores Cutia Therapeutics across four factors: quality 39/100, value 44/100. Its strongest factor is value.
2487 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $40.89M
- Revenue (TTM)
- $48.96M
- P/E
- —
- EPS
- -0.80
- Dividend yield
- —
- Beta (5Y)
- 0.78
- 52-week high
- HK$8.87
- 52-week low
- HK$0.60
- Avg volume (3M)
- —
- Shares outstanding
- 373.17M
- Employees
- 268
- Next earnings
- —
About Cutia Therapeutics
Cutia Therapeutics is a biopharmaceutical firm dedicated to establishing a robust dermatology platform for addressing conditions affecting both the skin and scalp. Its comprehensive therapeutic scope encompasses various dermatological challenges, including medications for localized fat accumulation, advanced care for scalp disorders, treatments for a wide array of skin ailments, and topical pain management. Founded in 2019, the company's main headquarters are situated in Shanghai, China, complemented by additional offices located in Beijing, Wuxi, and Hong Kong.
- ISIN
- KYG2606C1006
- Founded
- 2019
- Listed since
- Jun 12, 2023
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Aldeyra Therapeutics, Inc.NasdaqCM: ALDX | $42.23M | $0.70 | -23.59% |
| Dogwood Therapeutics, Inc.NasdaqCM: DWTX | $41.47M | $1.22 | -12.86% |
| Biomolecular Life Holdings, Inc.OTCPK: BIOM | $41.44M | $0.81 | -18.18% |
| KoBioLabs, IncKOSDAQ: A348150 | $40.93M | ₩2,810.00 | -2.43% |
| NurExone Biologic Inc.TSXV: NRX | $40.89M | CA$0.60 | -3.33% |
| INmune Bio Inc.NasdaqCM: INMB | $40.52M | $1.46 | -4.58% |
| TegoScience Inc.KOSDAQ: A191420 | $40.24M | ₩6,700.00 | -5.63% |
| Instil Bio, Inc.NasdaqCM: TIL | $40.08M | $5.91 | -12.31% |
Figures last refreshed Oct 18, 2026.